Sell Your Business in Maryland
Biotech, government-contracting services, and logistics anchor Maryland's acquisition activity, with the state's dense federal presence and I-270 life-sciences corridor drawing steady buyer interest.
Biotech, government-contracting services, and logistics anchor Maryland's acquisition activity, with the state's dense federal presence and I-270 life-sciences corridor drawing steady buyer interest.
Maryland's largest employment sectors, based on BLS state employment data — a proxy for where buyer demand is deepest.
| Sector | Employment |
|---|---|
| Government | 527,200 |
| Education & Health Services | 511,300 |
| Professional & Business Services | 470,600 |
| Trade, Transportation & Utilities | 448,500 |
| Leisure & Hospitality | 277,000 |
Biotech and life-sciences buyers are highly active along the I-270 corridor near Novavax and AstraZeneca/MedImmune, while government-services and defense-contracting acquirers target firms supporting NIH, FDA, and Aberdeen Proving Ground. Logistics consolidators tied to the Port of Baltimore and healthcare systems linked to Johns Hopkins round out Maryland's active buyer base.
See valuation ranges and business types for any industry in Maryland.
It depends on your industry and financials, but Maryland's biotech and healthcare businesses typically run 6–9x EBITDA, logistics and distribution businesses see 3–5x EBITDA, and government-services or professional-services firms typically land in the 1–2.5x revenue range. Get a free valuation for an exact estimate based on your numbers.
Most sales close in 3–6 months from the start of the process, depending on the business, its financial readiness, and how quickly a qualified buyer is identified.
Yes. Buyer sourcing and negotiations are handled discreetly so your employees, customers, and competitors don’t learn your business is for sale until you’re ready to disclose it.
Biotech and life-sciences buyers active along the I-270 corridor near Novavax and AstraZeneca/MedImmune, and government-services or defense-contracting acquirers targeting firms supporting NIH, FDA, and Aberdeen Proving Ground.